Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2 L PEG versus 2 L PEG plus simethicone for bowel preparation before colonoscopy
ChiCTR-IPR-15006181Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Apr 2015
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of macrogol and simethicone (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Efficacy of bowel preparation. Planned start Apr 2015; status: not yet recruiting.
02
Drugs
macrogolsimethicone
Beyond the preview
Go deeper on ChiCTR-IPR-15006181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006181.